Loading...
XNASLWAY
Market cap339mUSD
Dec 24, Last price  
22.94USD
1D
0.13%
1Q
-12.78%
Jan 2017
99.30%
Name

Lifeway Foods Inc

Chart & Performance

D1W1MN
XNAS:LWAY chart
P/E
29.90
P/S
2.12
EPS
0.77
Div Yield, %
0.00%
Shrs. gr., 5y
-1.54%
Rev. gr., 5y
9.15%
Revenues
160m
+13.11%
16,319,21020,131,65427,720,71338,729,15644,461,45558,115,87858,499,89369,970,40981,351,26597,524,142118,959,613118,587,000123,879,000118,893,000103,350,00093,662,000102,026,000119,065,000141,568,000160,123,000
Net income
11m
+1,130.19%
2,052,0592,548,4732,895,8243,152,6601,912,2755,569,7023,622,4662,855,4215,619,7984,974,9582,840,2101,972,0003,479,000-346,000-3,086,000453,0003,232,0003,311,000924,00011,367,000
CFO
17m
+324.91%
2,200,1691,592,4912,157,5032,347,1374,733,6607,603,0615,615,9434,042,0216,627,6845,841,1285,060,0556,745,0005,104,0003,808,0002,417,0003,811,0006,385,0005,564,0003,987,00016,941,000
Dividend
May 29, 20130.08 USD/sh
Earnings
Mar 18, 2025

Profile

Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
URL
https://lifewaykefir.com/
IPO date
Dec 29, 1988
Employees
289
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
160,123
13.11%
141,568
18.90%
119,065
16.70%
Cost of revenue
142,588
138,679
113,063
Unusual Expense (Income)
NOPBT
17,535
2,889
6,002
NOPBT Margin
10.95%
2.04%
5.04%
Operating Taxes
5,282
917
2,305
Tax Rate
30.12%
31.74%
38.40%
NOPAT
12,253
1,972
3,697
Net income
11,367
1,130.19%
924
-72.09%
3,311
2.44%
Dividends
Dividend yield
Proceeds from repurchase of equity
(3,997)
(1,583)
BB yield
4.58%
2.18%
Debt
Debt current
1,324
1,320
1,131
Long-term debt
1,719
5,532
6,548
Deferred revenue
(5,506)
Other long-term liabilities
5,506
147
Net debt
(10,155)
608
1,647
Cash flow
Cash from operating activities
16,941
3,987
5,564
CAPEX
(4,351)
(3,449)
(1,922)
Cash from investing activities
(4,410)
(4,029)
(7,142)
Cash from financing activities
(3,777)
(4,747)
2,885
FCF
10,976
(692)
3,727
Balance
Cash
13,198
4,444
9,233
Long term investments
1,800
(3,201)
Excess cash
5,192
79
Stockholders' equity
72,306
60,939
60,015
Invested Capital
58,201
53,854
55,578
ROIC
21.87%
3.60%
7.14%
ROCE
26.41%
5.08%
10.20%
EV
Common stock shares outstanding
15,103
15,718
15,773
Price
13.41
141.62%
5.55
20.65%
4.60
-14.97%
Market cap
202,531
132.17%
87,235
20.23%
72,556
-14.93%
EV
192,376
87,843
74,203
EBITDA
20,697
5,861
8,875
EV/EBITDA
9.29
14.99
8.36
Interest
384
267
116
Interest/NOPBT
2.19%
9.24%
1.93%